The Impact of Medication Adherence on Coronary Artery Disease Costs and Outcomes: A Systematic Review

被引:157
作者
Bitton, Asaf [1 ,2 ,3 ]
Choudhry, Niteesh K. [4 ]
Matlin, Olga S. [5 ]
Swanton, Kellie [4 ]
Shrank, William H. [4 ]
机构
[1] Brigham & Womens Hosp, Div Gen Med, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02120 USA
[3] Harvard Univ, Sch Med, Ctr Primary Care, Boston, MA 02120 USA
[4] Brigham & Womens Hosp, Div Pharmacoepidemiol, Boston, MA 02115 USA
[5] CVS Caremark, Northbrook, IL USA
关键词
Coronary artery disease; Costs; Medication adherence; Outcomes; Pharmacoeconomics; Systematic review; HEALTH-CARE COSTS; ACUTE MYOCARDIAL-INFARCTION; CARDIOVASCULAR EVENTS; DATABASE ANALYSIS; STATIN TREATMENT; HEART-DISEASE; MORTALITY; THERAPY; RISK; DISCONTINUATION;
D O I
10.1016/j.amjmed.2012.09.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Given the huge burden of coronary artery disease and the effectiveness of medication therapy, understanding and quantifying known impacts of poor medication adherence for primary and secondary prevention is crucial. We sought to systematically review the literature on this topic area with a focus on quantified cost and clinical outcomes related to adherence. METHODS: We conducted a systematic review of the literature between 1966 and November 2011 using a fixed search strategy, multiple reviewers, and a quality rating scale. We found 2636 articles using this strategy, eventually weaning them down to 25 studies that met our inclusion criteria. Three reviewers independently reviewed the studies and scored them for quality using the Newcastle Ottawa Scoring Scale. RESULTS: We found 5 studies (4 of which focused on statins) that measured the impact of medication adherence on primary prevention of coronary artery disease and 20 articles that focused on the relationship between medication adherence to costs and outcomes related to secondary prevention of coronary artery disease. Most of these latter studies focused on antihypertensive medications and aspirin. All controlled for confounding comorbidities and sociodemographic characteristics, but few controlled for likelihood of adherent patients to have healthier behaviors ("healthy adherer effect"). Three studies found that high adherence significantly improves health outcomes and reduces annual costs for secondary prevention of coronary artery disease (between $294 and $868 per patient, equating to 10.1%-17.8% cost reductions between high-and low-adherence groups). The studies were all of generally of high quality on the Newcastle Ottawa Scale (median score 8 of 9). CONCLUSIONS: Increased medication adherence is associated with improved outcomes and reduced costs, but most studies do not control for a "healthy adherer" effect. (C) 2013 Elsevier Inc. All rights reserved. . The American Journal of Medicine (2013) 126, 357.e7-357.e27
引用
收藏
页码:357.e7 / 357.e27
页数:21
相关论文
共 33 条
  • [1] Association of medical noncompliance and long-term adverse outcomes, after myocardial infarction in a minority and uninsured population
    Amin, Amit P.
    Mukhopadhyay, Ekanka
    Nathan, Sandeep
    Napan, Sirikarn
    Kelly, Russell F.
    [J]. TRANSLATIONAL RESEARCH, 2009, 154 (02) : 78 - 89
  • [2] Aubert RE, 2010, AM J MANAG CARE, V16, P459
  • [3] If You Build It, Will They Come? Designing Truly Patient-Centered Health Care
    Bechtel, Christine
    Ness, Debra L.
    [J]. HEALTH AFFAIRS, 2010, 29 (05) : 914 - 920
  • [4] Impact of adherence to statins on coronary artery disease in primary prevention
    Bouchard, Marie-Helene
    Dragomir, Alice
    Blais, Lucie
    Berard, Anick
    Pilon, Danielle
    Perreault, Sylvie
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (06) : 698 - 708
  • [5] The effect of discontinuation of antihypertensives on the risk of acute myocardial infarction and stroke
    Breekveldt-Postma, Nancy S.
    van Beest, Fernie J. A. Penning
    Siiskonen, Satu J.
    Falvey, Heather
    Vincze, Gabor
    Klungel, Olaf H.
    Herings, Ron M. C.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (01) : 121 - 127
  • [6] Association between adherence to calcium-channel blocker and statin medications and likelihood of cardiovascular events among US managed care enrollees
    Chapman, Richard H.
    Yeaw, Jason
    Roberts, Craig S.
    [J]. BMC CARDIOVASCULAR DISORDERS, 2010, 10
  • [7] Full Coverage for Preventive Medications after Myocardial Infarction
    Choudhry, Niteesh K.
    Avorn, Jerry
    Glynn, Robert J.
    Antman, Elliott M.
    Schneeweiss, Sebastian
    Toscano, Michele
    Reisman, Lonny
    Fernandes, Joaquim
    Spettell, Claire
    Lee, Joy L.
    Levin, Raisa
    Brennan, Troyen
    Shrank, William H.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (22) : 2088 - 2097
  • [8] Better compliance to antihypertensive medications reduces cardiovascular risk
    Corrao, Giovanni
    Parodi, Andrea
    Nicotra, Federica
    Zambon, Antonella
    Merlino, Luca
    Cesana, Giancarlo
    Mancia, Giuseppe
    [J]. JOURNAL OF HYPERTENSION, 2011, 29 (03) : 610 - 618
  • [9] Results of a Retrospective Database Analysis of Adherence to Statin Therapy and Risk of Nonfatal Ischemic Heart Disease in Daily Clinical Practice in Italy
    Corrao, Giovanni
    Conti, Valentino
    Merlino, Luca
    Catapano, Alberico L.
    Mancia, Giuseppe
    [J]. CLINICAL THERAPEUTICS, 2010, 32 (02) : 300 - 310
  • [10] Patient adherence and medical treatment outcomes - A meta-analysis
    DiMatteo, MR
    Giordani, PJ
    Lepper, HS
    Croghan, TW
    [J]. MEDICAL CARE, 2002, 40 (09) : 794 - 811